Brief: Sun Pharma Says Its Unit DUSA Pharmaceuticals Reached Settlement With Biofrontera
30/11/2021 09:10
Nov 30 (Reuters) - Sun Pharmaceutical Industries Ltd
SUN.NS :
* SUN PHARMA - UNIT REACHED SETTLEMENT WITH BIOFRONTERA
RESOLVING
LITIGATION
* SUN PHARMA - DUSA PHARMA WILL RECEIVE $22.5 MILLION FROM
BIOFRONTERA
* SUN PHARMA - ADDITIONAL DETAILS REGARDING SETTLEMENT ARE
CONFIDENTIAL
Source text for Eikon: ID:nBSE1sLGFX
Further company coverage: SUN.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million